Eevia Health Plc received new sales order for Feno-Sambucus™ for the equivalent of c. SEK 34.4 million
Following a successful exhibition at the Supply Side West trade show in Las Vegas, US, last week, Eevia Health ("Eevia" or "The Company") received an order for the Feno-Sambucus™ equaling a revenue of SEK 34.4 million. The order is a new contractual volume section related to a five-year Sales Agreement with a US brand owner. The new section has adjusted prices and terms.Eevia Health Plc is a leading health ingredient manufacturer from Finland and is currently the largest manufacturer of elderberry extract in the world. Eevia has received a call-off for quantities for November 2022 –